Entity Common Stock, Shares Outstanding of Enveric Biosciences, Inc. from 01 Aug 2011 to 24 Mar 2026
- Taxonomy & unit
- dei: shares
- Description
- Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
- Summary
-
Enveric Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2011 to 24 Mar 2026.
- Enveric Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 24 Mar 2026 was 1,887,535, a 24% decline year-over-year.
- Source SEC data
- View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)
Enveric Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | 1,887,535 | -584,121 | -24% | 24 Mar 2026 | 10-K | 27 Mar 2026 | 2025 | FY |
| Q3 2025 | 596,978 | -9,347,942 | -94% | 12 Nov 2025 | 10-Q | 14 Nov 2025 | 2025 | Q3 |
| Q2 2025 | 3,246,284 | -5,673,636 | -64% | 13 Aug 2025 | 10-Q | 14 Aug 2025 | 2025 | Q2 |
| Q1 2025 | 2,471,656 | -4,822,349 | -66% | 27 Mar 2025 | 10-K | 28 Mar 2025 | 2024 | FY |
| Q3 2024 | 9,944,920 | +7,623,605 | +328% | 12 Nov 2024 | 10-Q | 14 Nov 2024 | 2024 | Q3 |
| Q2 2024 | 8,919,920 | +6,772,014 | +315% | 09 Aug 2024 | 10-Q | 12 Aug 2024 | 2024 | Q2 |
| Q1 2024 | 7,294,005 | +5,215,734 | +251% | 21 Mar 2024 | 10-K | 26 Mar 2024 | 2023 | FY |
| Q3 2023 | 2,321,315 | +243,044 | +12% | 09 Nov 2023 | 10-Q | 13 Nov 2023 | 2023 | Q3 |
| Q2 2023 | 2,147,906 | +573,142 | +36% | 09 Aug 2023 | 10-Q | 11 Aug 2023 | 2023 | Q2 |
| Q1 2023 | 2,078,271 | -50,506,849 | -96% | 30 Mar 2023 | 10-K/A | 09 Jun 2023 | 2022 | FY |
| Q3 2022 | 2,078,271 | -29,305,361 | -93% | 11 Nov 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | 1,574,764 | -19,857,651 | -93% | 11 Aug 2022 | 10-Q | 12 Aug 2022 | 2022 | Q2 |
| Q1 2022 | 52,585,120 | +33,134,613 | +170% | 30 Mar 2022 | 10-K | 31 Mar 2022 | 2021 | FY |
| Q3 2021 | 31,383,632 | +23,892,088 | +319% | 09 Nov 2021 | 10-Q | 15 Nov 2021 | 2021 | Q3 |
| Q2 2021 | 21,432,415 | +15,695,414 | +274% | 13 Aug 2021 | 10-Q | 13 Aug 2021 | 2021 | Q2 |
| Q1 2021 | 19,450,507 | +16,203,802 | +499% | 29 Mar 2021 | 10-K | 01 Apr 2021 | 2020 | FY |
| Q3 2020 | 7,491,544 | -55,329,245 | -88% | 13 Nov 2020 | 10-Q | 16 Nov 2020 | 2020 | Q3 |
| Q2 2020 | 5,737,001 | -46,680,687 | -89% | 11 Aug 2020 | 10-K/A | 12 Aug 2020 | 2019 | FY |
| Q1 2020 | 3,246,705 | -43,781,728 | -93% | 22 Mar 2020 | 10-K | 25 Mar 2020 | 2019 | FY |
| Q3 2019 | 62,820,789 | +23,213,220 | +59% | 06 Nov 2019 | 10-Q | 08 Nov 2019 | 2019 | Q3 |
| Q2 2019 | 52,417,688 | +29,544,241 | +129% | 09 Aug 2019 | 10-Q | 14 Aug 2019 | 2019 | Q2 |
| Q1 2019 | 47,028,433 | +28,237,435 | +150% | 22 Mar 2019 | 10-K | 26 Mar 2019 | 2018 | FY |
| Q3 2018 | 39,607,569 | +23,751,320 | +150% | 08 Nov 2018 | 10-Q | 14 Nov 2018 | 2018 | Q3 |
| Q2 2018 | 22,873,447 | +8,223,035 | +56% | 08 Aug 2018 | 10-Q | 14 Aug 2018 | 2018 | Q2 |
| Q1 2018 | 18,790,998 | +4,211,581 | +29% | 29 Mar 2018 | 10-K | 02 Apr 2018 | 2017 | FY |
| Q3 2017 | 15,856,249 | +1,970,277 | +14% | 30 Oct 2017 | 10-Q | 13 Nov 2017 | 2017 | Q3 |
| Q2 2017 | 14,650,412 | +1,164,940 | +8.6% | 10 Aug 2017 | 10-Q | 14 Aug 2017 | 2017 | Q2 |
| Q1 2017 | 14,579,417 | +2,705,056 | +23% | 20 Mar 2017 | 10-K/A | 04 Apr 2017 | 2016 | FY |
| Q3 2016 | 13,885,972 | 14 Nov 2016 | 10-Q | 14 Nov 2016 | 2016 | Q3 | ||
| Q2 2016 | 13,485,472 | 12 Aug 2016 | 10-Q | 12 Aug 2016 | 2016 | Q2 | ||
| Q1 2016 | 11,874,361 | -3,535,638 | -23% | 15 Mar 2016 | 10-KT | 15 Mar 2016 | 2015 | T3 |
| Q4 2015 | 11,639,066 | 16 Nov 2015 | 10-Q | 23 Nov 2015 | 2016 | Q2 | ||
| Q1 2015 | 15,409,999 | 0 | 0% | 20 Mar 2015 | 10-K | 31 Mar 2015 | 2014 | FY |
| Q3 2014 | 15,409,999 | +3,267,999 | +27% | 10 Nov 2014 | 10-Q | 18 Aug 2015 | 2015 | Q1 |
| Q2 2014 | 15,409,999 | +3,267,999 | +27% | 20 Jul 2014 | 10-Q | 13 Nov 2014 | 2014 | Q3 |
| Q1 2014 | 15,409,999 | +3,267,999 | +27% | 01 May 2014 | 10-Q/A | 08 May 2014 | 2014 | Q1 |
| Q3 2013 | 12,142,000 | 0 | 0% | 30 Sep 2013 | 10-Q | 06 Nov 2013 | 2013 | Q3 |
| Q2 2013 | 12,142,000 | 0 | 0% | 31 Jul 2013 | 10-Q | 01 Aug 2013 | 2013 | Q2 |
| Q1 2013 | 12,142,000 | 0 | 0% | 28 Feb 2013 | 10-K | 28 Feb 2013 | 2012 | FY |
| Q3 2012 | 12,142,000 | 0 | 0% | 09 Nov 2012 | 10-Q | 13 Nov 2012 | 2012 | Q3 |
| Q2 2012 | 12,142,000 | -52,858,000 | -81% | 31 Jul 2012 | 10-Q | 01 Aug 2012 | 2012 | Q2 |
| Q1 2012 | 12,142,000 | 03 Mar 2012 | 10-K | 07 Mar 2012 | 2011 | FY | ||
| Q3 2011 | 12,142,000 | 31 Oct 2011 | 10-Q | 14 Nov 2011 | 2011 | Q3 | ||
| Q2 2011 | 65,000,000 | 01 Aug 2011 | 10-Q | 02 Aug 2011 | 2011 | Q2 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.